Algorithm Helps Manage ALCL Worries after Breast Augmentation

New Update Provides 'Rational Approach' to Evaluating Lumps and Swelling in Breasts with Implants, Reports Plastic and Reconstructive Surgery journal

Newswise — Philadelphia, Pa. (February 14, 2011) – In the wake of a recent FDA statement linking breast implants to a rare cancer called anaplastic large cell lymphoma (ALCL), a newly updated algorithm provides plastic surgeons with guidance in managing women with breast lumps or swelling after breast augmentation. The algorithm appears in an article published on the website of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The article will be published in the June 2011 print issue of the journal.

The algorithm "specifically addresses additional diagnosis and management alternatives for management of seroma in breast augmentation patients that may relate to lymphoproliferative disorders or ALCL," writes Dr. John B. Tebbetts, a Dallas plastic surgeon.

Stepwise Approach Guides Decision-Making by Surgeons and PatientsDr. Tebbetts presents an update of a previous algorithm on the diagnosis and management of seromas after breast augmentation surgery. Seromas are collections of wound fluid (serum) that can develop after various types of surgery. The update was prompted by reports of ALCL and other lymphoproliferative disorders developing in women who have undergone breast augmentation. Based on these reports, the FDA has issued a statement warning of "a very small, but increased risk" of ALCL in women with breast implants. The link to ALCL poses a challenge for plastic surgeons, because ALCL may first appear as a painful lump or swelling in the operated breast. That's very similar to the symptoms of seroma—a much more common, but less serious, problem after breast augmentation. Since the FDA statement, plastic surgeons and their patients are seeking a rational approach to diagnosis and treatment of lumps or swelling associated with breast implants.

In developing the updated algorithm, Dr. Tebbetts' goal was to "increase awareness and vigilance" for the possibility of ALCL when evaluating fluid collections occurring six months or longer after breast augmentation. The algorithm includes "a sequential set of alternatives" for surgeons to discuss with patients, prioritized to lead to an accurate diagnosis of ALCL if it's present—and to avoid unnecessary reoperation if it's not.

The algorithm can serve as a useful framework for discussion, helping patients to make an informed decision regarding their diagnostic and treatment options. For each management alternative—from diagnostic needle aspiration, to various options for reoperation, to doing nothing—the potential advantages and risks/tradeoffs are listed.

The algorithm will be further updated as more evidence comes to light. Ongoing initiatives by the FDA and ASPS, among others, will help to define the true relationship between breast augmentation and ALCL—if any. Until more definitive information becomes available, Dr. Tebbetts believes the updated algorithm will provide a valuable "interim summary of alternatives" for plastic surgeons and other health care professionals involved in the care of women with breast implants.

Plastic and Reconstructive Surgery® is published by Lippincott Williams & Wilkins, part of Wolters Kluwer Health.

About Plastic and Reconstructive SurgeryFor more than 60 years, Plastic and Reconstructive Surgery®> has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair, and cosmetic surgery, as well as news on medico-legal issues.

About ASPSThe American Society of Plastic Surgeons is the largest organization of board-certified plastic surgeons in the world. Representing more than 7,000 physician members, the Society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. About Lippincott Williams & Wilkins Lippincott Williams & Wilkins (LWW) is a leading international publisher for healthcare professionals and students with nearly 300 periodicals and 1,500 books in more than 100 disciplines publishing under the LWW brand, as well as content-based sites and online corporate and customer services.

LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools, journals, and textbooks, such as Lippincott Williams & Wilkins and ; and electronic information providers, such as Ovid®, UpToDate®, Medi-Span®, Facts & Comparisons®, and ProVation® Medical.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company focused on professionals with annual revenues (2009) of €3.4 billion ($4.8 billion), approximately 19,300 employees worldwide and operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Visit our website, YouTube or follow @Wolters_Kluwer on Twitter for more information about our market positions, customers, brands and organization.